AXGN Q1 2017 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q1 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$12M+50.9% YoY

Gross Profit

$10M84.3% margin

Operating Income

-$3M-26.1% margin

Net Income

-$4M-30.7% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+7.3%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$848,589

Balance Sheet

Total Assets

$43M

Total Liabilities

$31M

Stockholders' Equity

$12M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$8M	+50.9%
Gross Profit	$10M	$7M	+54.0%
Operating Income	-$3M	-$3M	-22.0%
Net Income	-$4M	-$4M	-2.3%